MétaCan
Menu
Back to cohort
Record W4415450100 · doi:10.1210/jendso/bvaf149.1662

SUN-077 Immune Checkpoint Inhibitor-induced Hypophysitis In Adults: A Systematic Review Of Clinical Patterns And Hormonal Recovery

2025· article· en· W4415450100 on OpenAlexaboutno aff
Ana Clara Bocato, Luiza Dotto, Daniel Santos, José Nogueira da Silva Neto, Fernanda Gabriele Pedroso Ecamila Ecamila, Andrielly Collioni Beatricci, Bárbara Vieira, Giovanna Bifulco Soares, Júlia Gallardo Gomes Alciati

Bibliographic record

VenueJournal of the Endocrine Society · 2025
Typearticle
Languageen
FieldMedicine
TopicPharmacological Effects and Toxicity Studies
Canadian institutionsnot available
Fundersnot available
KeywordsHypophysitisAdverse effectEndocrine systemHormoneImmune systemImmunotherapyAdrenal insufficiencyRash

Abstract

fetched live from OpenAlex

Abstract Disclosure: A.C. Bocato: None. L. Dotto: None. D.M. Santos: None. J.N. Silva Neto: None. F.G. Ecamila: None. A.L. Barbosa: None. A.C. Beatricci: None. B.R. Vieira: None. G.B. Soares: None. J.G. Alciati: None. Introduction: Immune checkpoint inhibitor-induced hypophysitis (ICI-H) is a significant endocrine toxicity related to oncologic immunotherapy, characterized by inflammation of the anterior pituitary and persistent hormonal dysfunction. This study aims to review the clinical manifestations of ICI-H in adults, focusing on the frequency of hormonal deficits, disease progression, and factors associated with either recovery or persistence of endocrine dysfunction. Methods: A systematic review was conducted in the PubMed, SciELO, and BVS databases, using MeSH descriptors and free terms related to immune checkpoint inhibitors, hypophysitis, and cancer. Primary clinical studies involving adult patients with clinical, hormonal, and/or imaging data related to ICI-H were included. Pediatric studies, studies without relevant clinical data, and those that addressed hypophysitis only as a secondary adverse event were excluded. Study quality was assessed using the Jadad and Newcastle-Ottawa Scales. Results: Nine studies were included. Most patients presented with adrenal axis deficiency as the main dysfunction, often without recovery during follow-up. Thyroid and gonadal axis dysfunctions were also observed, with partial recovery in a few cases. High-dose glucocorticoid therapy, evaluated in a clinical trial, did not improve pituitary function recovery and was associated with adverse metabolic effects. Patients receiving combined immunotherapy regimens (anti-CTLA-4 + anti-PD-1) showed a higher frequency and severity of hypophysitis. Some studies identified potential predictive markers, including hematologic and genetic alterations, as well as characteristic findings on imaging. Nevertheless, diagnostic criteria remain variable, and there is no consensus on optimal treatment strategies. Conclusion: ICI-H is a clinically relevant condition, often marked by abrupt hormonal dysfunction with incomplete recovery. Adrenal axis deficiency is predominant, and high-dose glucocorticoid therapy has not shown functional benefit. Identifying risk markers and standardizing diagnostic criteria are key priorities for the appropriate management of affected patients. Presentation: Sunday, July 13, 2025

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.016
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.009
Threshold uncertainty score0.020

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.016
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0050.005
Bibliometrics0.0090.010
Science and technology studies0.0000.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.350
Teacher spread0.329 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Endocrine SocietySame topicPharmacological Effects and Toxicity StudiesFrench-language works237,207